Aristotle University Of Thessaloniki (AUTH)
Αξιολόγηση εξονικών πολυμορφισμών σε CpG αλληλουχίες και ενισχυτές ματίσματος σε γονίδια που συνδέονται με διαβήτη τύπου ΙΙ: διερεύνηση σε ελληνικό πληθυσμό
Abstract
dc:descriptionGenome-wide approaches search the whole genome for causal genetic variants in order to identify heritable DNA modifications associated with various complex diseases. DNA polymorphisms studied by these approaches are independent of their relation with coding protein, protein expression and associated pathological conditions. However, most studies involve protein coding SNPs.Although such studies contribute considerably to the identification of disease-related heritable genetic variation, small and targeted studies can contribute to our understanding of the mechanisms involved in gene expression. In order to consider the impact of expression-related regulatory (splicing, epigenetic) parameters, the evaluation of genetic variation related to synonymous SNPs in splice-sites and serine-rich exonic splicing enhancers (SS and SR ESEs) and in epigenetic sites was undertaken in this dissertation.Splicing, as a disease-related condition, has been previously evaluated by bioinformatic tools in recent studies. Actually, in a previously published study we had identified several synonymous SNPs leading to major modifications of the splicing regulatory parameters (ESEs) and epigenetic (CpG) sites. Type 2 diabetes is associated with changes in the expression levels of several genes and also, synonymous SNPs may be actively involved in gene expression and their study could be useful in identifying key genetic variants associated with type 2 diabetes. One of the most important gene expression regulatory parameters is the production of various splice products - protein isoforms that allow the location and the regulation of the procedures involved. The aim of this study was to evaluate the importance of the site selection affecting gene expression and especially, splicing regulation.In the first part of the present dissertation, all genes reported in previous publications to be associated with type 2 diabetes were collected. Then, all synonymous SNPs observed in their coding sequences, their presence in alternative or constitutive exons and the formation or distraction of a CpG site by one of the alleles introduced by a SNP were recorded. Finally, the synonymous SNPs affecting splicing regulatory elements in DNA (SS and SR ESEs) by changing the splicing score were identified using bioinformatics tools and recorded. Synonymous SNPs that cause maximum splicing score changes of SS and SR ESEs were studied. Provided that synonymous SNPs are not frequent in ESEs, this analysis resulted in the identification of 232 (35%) synonymous polymorphisms from a total of 670 exonic SPNs, 73 (10%) of which are coding synonymous with major splicing effect in SS and SR ESEs, 8 (1.2%) of which were in alternative exons in genes associated with type 2 diabetes. More than half (56%) of ESE- related synonymous SPNs with major splicing effect were found in CpG sites, tentative DNA methylation sites. From these SNPs two were selected: rs3749166 in the CAPN10 gene (calpain 10), which encodes a nonlysosomal cysteine enzyme with a protease activity that acts as membrane transporter translocator modifying, among other activities, the activity of glucose transporter 4 and rs5404 in gene SLC2A2 (solute carrier family 2, member 2), a facilitated glucose transporter in liver and pancreatic islet β-cells. The first SNP, rs3749166, affects a splice-site ESE, while the second, rs5404, alters an ESE recognizing multiple SR proteins. The above SNPs were identified in a sample of the Greek population consisting of 45 males and 125 females, 71 of which were diagnosed with type 2 diabetes,the rest being the control group. In this sample the SNP rs3749166 (G>A) was observed in 67 diabetic patients and in 83 control subjects. This SNP was found to be associated with type 2 diabetes while the polymorphic allele A was related to high diabetic risk. The next SNP, rs5404(C>T) was detected in 16 diabetic patients and 39 control subjects and in this case, the polymorphic allele T of rs5404 appeared to be protective for type 2 diabetes while its genotype CC had enhanced disease risk. Genotype TT was not observed in any of the individuals in our sample (0-1.7%). Our results were in accordance with previous study, which has shown the association of rs3749166 with type 2 diabetes. Regarding the SNP rs5404, for which the results were controversial, the outcome was in accordance with previous study, which associated rs5404 with type 2 diabetes, although in another study the polymorphic allele rs5404 was only associated with enhanced risk for type 2 diabetes. In the presence of both rs3749166 and rs5404 in the diabetic patients, rs3749166 and especially, its polymorphic allele A, was associated with high risk predisposition for type 2 diabetes compared to rs5404. Additionally, genotype AG of rs3749166 was associated with disease diagnosis at a younger age and early disease onset. The critical regulatory markers of type 2 diabetes, fasting glucose and glycosylated hemoglobin were associated with disease complications (diabetic angiopathy and neuropathy) and high levels of glycosylated hemoglobin were related to deleterious genotype AGCC.In our study the removal of a CpG site was correlated either positively (rs5404) or negatively (rs3749166) with disease. Especially, the presence of a CpG site was protective in the case of rs3749166 (allele G protective) and harmful in the case of rs5404 (allele C deleterious) with respect to type 2 diabetes. This means, that evolutionary CpG sites loss might be protective or deleterious and there was no a-priori selection for the one or the other way, at least, as far as, genes associated with degenerative diseases, like type 2 diabetes is concerned.In our results, the frequency of synonymous exonic SPNs in splicing regulatory sites-ESEs and in alternative exons was low (high preservation), indicating the crucial role of these sites in gene function. The high frequency of synonymous exonic SPNs in epigenetic sites found, links DNA methylation with alternative splicing, proved the role of epigenetic SNPs in splicing and gene expression.Our study showed that two synonymous SNPs, selected according to bioinformative analysis on the basis of the functional genomic characteristics introduced in epigenetic and splicing regulatory elements were probably very significantly associated with type 2 diabetes susceptibility in the Greek population. The procedure presented for selecting SNPs affecting gene expression, could be useful for building risk-associated genotypes on the basis of biology predictive models and functional genetic studies, thus simplifying the procedures followed by large scale studies. Finally, our knowledge of epigenetic SPNs could promote the significance of adopting prevention programs for high-risk individuals for the disease.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karambataki, Maria
- Καραμπατάκη, Μαρία
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35281